GOFFRINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 5.296
AS - Asia 4.516
EU - Europa 3.179
SA - Sud America 624
AF - Africa 205
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.833
Nazione #
US - Stati Uniti d'America 5.144
SG - Singapore 1.715
CN - Cina 1.178
VN - Vietnam 747
IE - Irlanda 610
IT - Italia 589
BR - Brasile 469
SE - Svezia 433
FI - Finlandia 353
HK - Hong Kong 351
UA - Ucraina 324
DE - Germania 288
ZA - Sudafrica 154
NL - Olanda 138
FR - Francia 137
BD - Bangladesh 121
GB - Regno Unito 112
TR - Turchia 108
CA - Canada 106
RU - Federazione Russa 60
IN - India 47
CL - Cile 45
AR - Argentina 43
IQ - Iraq 36
AT - Austria 28
MX - Messico 28
BE - Belgio 27
KR - Corea 27
EC - Ecuador 24
JP - Giappone 23
PH - Filippine 19
ID - Indonesia 18
PK - Pakistan 17
ES - Italia 15
PL - Polonia 15
UZ - Uzbekistan 15
CO - Colombia 13
JO - Giordania 11
SA - Arabia Saudita 10
VE - Venezuela 10
EG - Egitto 9
LT - Lituania 9
TH - Thailandia 9
MA - Marocco 8
PY - Paraguay 8
TW - Taiwan 8
IL - Israele 7
KE - Kenya 7
AU - Australia 6
CI - Costa d'Avorio 6
PT - Portogallo 6
TN - Tunisia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
GE - Georgia 5
MY - Malesia 5
BY - Bielorussia 4
EU - Europa 4
IR - Iran 4
LB - Libano 4
PE - Perù 4
RO - Romania 4
CY - Cipro 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
LY - Libia 3
NP - Nepal 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
CH - Svizzera 2
DK - Danimarca 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 13.820
Città #
Singapore 799
Dublin 610
Ashburn 585
San Jose 513
Chandler 482
Santa Clara 466
Jacksonville 352
Hong Kong 332
Beijing 280
Ho Chi Minh City 222
Dearborn 210
Boardman 190
Hanoi 161
Ann Arbor 150
Dallas 148
Los Angeles 147
Parma 146
Johannesburg 137
Nanjing 127
Princeton 109
San Mateo 98
Lauterbourg 94
New York 92
Izmir 90
Wilmington 85
Shanghai 80
Toronto 62
Munich 54
Helsinki 45
Jinan 45
Shenyang 41
Hefei 38
Moscow 38
Nanchang 37
Buffalo 35
Council Bluffs 35
Columbus 34
São Paulo 34
Kunming 30
Tianjin 29
Milan 27
Da Nang 26
Haiphong 26
Santiago 26
Woodbridge 25
Changsha 24
Chicago 23
Guangzhou 23
Des Moines 22
Jiaxing 22
London 22
Nuremberg 22
Brussels 21
Rio de Janeiro 21
Rome 20
Vienna 20
Brooklyn 19
Falls Church 19
Tokyo 19
Zhengzhou 18
Bologna 17
Houston 17
The Dalles 16
Orem 15
Biên Hòa 14
Hebei 14
Baghdad 13
Tashkent 13
Atlanta 12
Brasília 12
Curitiba 12
Jakarta 12
Norwalk 12
Seattle 12
Seoul 12
Hải Dương 11
Modena 11
Montreal 11
Pittsburgh 11
Redmond 11
Warsaw 11
Amman 10
Ardea 10
Mexico City 10
Turku 10
Amsterdam 9
Belo Horizonte 9
Boston 9
Denver 9
Guayaquil 9
Phoenix 9
Quito 9
San Francisco 9
Berlin 8
Fremont 8
Hangzhou 8
Scafati 8
Abbiategrasso 7
Bogotá 7
Bắc Ninh 7
Totale 8.141
Nome #
Yeast-Based Functional Investigation of ELAC2 Variants in Mitochondrial Dysfunction 200
DNA polymerase [gamma] and disease: what we have learned from yeast 198
Biallelic Mutations in DNM1L are Associated with a Slowly Progressive Infantile Encephalopathy 187
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 187
Yeast as a model for mitochondrial aminoacyl-tRNA synthetase disorders: validation of mutations in NARS2 and WARS2 186
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 182
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models 178
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 177
Exploring Yeast as a Study Model of Pantothenate Kinase-Associated Neurodegeneration and for the Identification of Therapeutic Compounds 177
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 164
Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy 164
S. cerevisiae carrying a MGM1/OPA1 chimeric gene: a model for the study of dominant optic atrophy and for drug discovery 163
Functional characterization of archaic-specific variants in mitonuclear genes: insights from comparative analysis in S. cerevisiae 161
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 161
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations 161
Yeast as a model system for diseases associated with defective coenzyme a metabolism 159
Behaviour of Saccharomyces cerevisiae wine strains during adaptation to unfavourable conditions of fermentation on synthetic medium: Cell lipid composition, membrane integrity, viability and fermentative activity 159
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 159
Carbon catabolite repression in Kluyveromyces lactis: isolation and characterization of the KlDLD gene encoding the mitochondrial enzyme D-lactate ferricytochrome c oxidoreductase. 157
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 156
A yeast model for PKAN and CoPAN neurodegeration 154
Cloning and characterization of the lactate-specific inducible gene KlCYB2, encoding the cytochrome b2 of Kluyveromyces lactis 150
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 149
Modeling in yeast of KARS pathogenic variants associated with a progressive and multi-systemic disease: impact on cytosolic and mitochondrial isoforms 149
Expanded phenotype of AARS1-related white matter disease. 147
A novel de novo dominant mutation in ISCU associated with mitochondrial myopathy. 146
Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome 145
Recessive germline SDHA and SDHB mutations causing leukodystrophy and isolated mitochondrial complex II deficiency. 144
Modeling human coasy mutations in yeast Saccharomyces cerevisiae 141
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 141
Bi-allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease 140
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 136
Mitochondrial disorders caused by mutations impairing miotchondrial dynamics 135
Investigation in yeast of novel variants in mitochondrial aminoacyl-tRNA synthetases WARS2, NARS2, and RARS2 genes associated with mitochondrial diseases 134
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 134
RAG1 and RAG2: nuclear genes involved in the dependence/independence on mitochondrial respiratory function for growth on sugars 132
Extension of Chronological Lifespan by Hexokinase Mutation in Kluyveromyces lactis Involves Increased Level of the Mitochondrial Chaperonin Hsp60. 131
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 131
"Miglioramento genetico di Kluyveromyces lactis per la produzione di proteine eterologhe 131
Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. 130
The impairment of HCCS leads to MLS syndrome by activating a non-canonical cell death pathway in the brain and eyes. 130
Alterations of O-glycosylation, cell wall, and mitochondrial metabolism in Kluyveromyces lactis cells defective in KlPmr1p, the Golgi Ca2+-ATPase 130
Comparative Functional Genomics of glucose repression in laboratory and wine yeasts 129
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 129
"A Kluyveromyces lactis gene homologous to AAC2 complements the Saccharomyces cerevisiae op1 mutation" 128
Identificazione e caratterizzazione molecolare di soppressori multicopia dei mutanti fog in Kluyveromyces lactis 125
The respiratory activities of four Hansenula species. 125
Genetic improvement of the yeast Kluyveromyces lactis for biotechnological purposes 122
A phosphoglucose isomerase gene is involved in the Rag phenotype of the yeast Kluyveromyces lactis. 120
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 120
RAG4 Gene Encodes a Glucose Sensor in Kluyveromyces lactis 119
Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation 119
Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. 118
A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency 118
Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene 116
The power of yeast in modeling human mutations leading to mitochondrial disease 116
Guidelines and recommendations on yeast cell death nomenclature. 115
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 114
Elementi regolativi implicati nel processo di repressione /derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 113
A respiratory-deficient mutation associated with high salt sensitivity in Kluyveromyces lactis 112
FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis are homologous to GAL83 and SNF1 of Saccharomyces cerevisiae 112
Three target genes for the transcriptional activator Cat8p of Kluyveromyces lactis: acetyl coenzyme A synthetase genes KlACS1 and KlACS2 and lactate permease gene KlJEN1 111
Oxygen is required to restore flor strain viability and lipid biosynthesis under fermentative conditions 109
Galactose transport in Kluyveromyces lactis: a genomic approach 109
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 109
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 109
Evidence for a Conserved Function of Eukaryotic Pantothenate Kinases in the Regulation of Mitochondrial Homeostasis and Oxidative Stress 107
SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. 107
Effetto del metabolismo fermentativo/ ossidativo e della repressione da glucosio nella produzione di proteine eterologhe in Kluyveromyces lactis 105
Genetic improvement of recombinant protein production in Kluyveromyces lactis 104
Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease 104
FLO11 expression and lipid biosynthesis are required for air-liquid biofilm formation in a Saccharomyces cerevisiae flor strain 103
Galactose transport in Kluyveromyces lactis: a genomic approach 103
The Golgi Ca2+-ATPase KlPmr1p function is required for oxidative stress response by controlling the expression of the heat-shock element HSP60 in Kluyveromyces lactis 102
ISOLATION AND CHARACTERIZATION OF CARBON CATABOLITE REPRESSION MUTANTS IN SACCHAROMYCES CEREVISIAE. 102
Respiration-dependent utilization of sugars in yeast: a determinant role of sugar transporter 102
Autosomal dominant myopathy caused by a novel ISCU variant 101
Genetic improvement of the yeast Kluyveromyces lactis for biotechnological purposes 101
Severe mitochondrial encephalomyopathy caused by de novo variants in OPA1 gene 100
Inactivation of the Kluyveromyces lactis KICOX14 gene leads to an alteration in the expression of KLADH3 and KLADH4 100
Isolation and molecular characterization of KlCOX14, a gene of Kluyveromyces lactis encoding a protein necessary for the assembly of the cytochrome oxidase complex 100
Galactose transport in Kluyveromyces lactis 99
Rag4 gene encodes a glucose sensor in Kluyveromyces lactis 98
The in vivo effect of acriflavine on mitochondrial functions in the petite-negative yeast Hansenula saturnus 98
Role du facteur transcriptionel HAP2p dans l’activation du gène codant pour l’enzyme mitochondrial D-lacticodeshydrogénase chez S. cerevisiae et K. lactis 98
Regulation of primary carbon metabolism in Kluyveromyces lactis 98
Influence of mutations in hexose transporter genes on glucose repression in Kluyveromyces lactis. 97
Genes release galactose and raffinose utilization from mitochondrial control in Kluyveromyces lactis 95
Galactose transport in Kluyveromyces lactis: major role of the glucose permease Hgt1 95
The effects of glucose repression and fermentative/oxidative metabolism on heterologous protein production in Kluyveromyces lactis 95
Improved Production of Heterologous Proteins by a Glucose Repression-Defective Mutant of Kluyveromyces lactis 94
MUF1 gene, a multycopy suppressor of fog mutants in Kluyveromyces lactis, encodes a transcriptional activator 92
RAG1 gene of the yeast Kluyveromyces lactis codes for a sugar transporter 91
Respiratory pathways in Hansenula saturnus 91
Severe Infantile Encephalomyopathy Caused by a Mutation in COX6B1, a Nucleus-Encoded Subunit of Cytochrome C Oxidase. 91
Saccharomyces cerevisiae genes release galactose and raffinose utilization from respiration control in Kluyveromyces lactis 91
Identificazione e caratterizzazione del gene ERO1 di Kluyveromyces lactis potenzialmente coinvolto nel ripiegamento delle proteine nel reticolo endoplasmatico 91
Lipid Metabolism Related To Stuck Fermentation In Saccharomyces cerevisiae Wine Strains 90
IMP2, a gene involved in the expression of glucose-repressible gene in Saccharomyces cerevisiae 90
Elementi regolativi implicati nel processo di repressione/derepressione da glucosio in Kluyveromyces lactis: differenze rispetto a Saccharomyces cerevisiae 89
Totale 12.637
Categoria #
all - tutte 47.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022575 23 11 5 25 22 22 84 89 30 55 40 169
2022/20231.834 216 176 117 137 156 193 21 116 622 9 52 19
2023/2024755 42 71 12 33 50 163 85 51 18 67 75 88
2024/20252.626 32 135 168 147 322 413 57 109 387 230 161 465
2025/20265.145 460 436 579 475 686 282 670 134 725 394 175 129
Totale 14.072